Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia-Reference-Cited by-同舟云学术

Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia

Published:2021-09-13 Issue:12 Volume:36 Page:2951-2957
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Movement Disorders

Author:

Veenhuis Stefanie J.G.¹²^ORCID,Os Nienke J.H.²³,Janssen Anjo J.W.M.⁴,Gerven Marjo H.J.C.⁴,Coene Karlien L.M.⁵,Engelke Udo. F.H.⁵,Wevers Ron A.⁵,Tinnevelt Gerjen H.⁶,Heine Rob⁷⁸,Warrenburg Bart P.C.²³⁹,Weemaes Corry M.R.¹,Roeleveld Nel⁸¹⁰,Willemsen Michèl A.A.P.¹²⁹¹¹

Affiliation:

1. Department of Pediatrics Amalia Children's Hospital, Radboud University Medical Center Nijmegen The Netherlands

2. Donders Institute for Brain, Cognition and Behavior Radboud University Medical Center Nijmegen The Netherlands

3. Department of Neurology Radboud University Medical Center Nijmegen The Netherlands

4. Department of Rehabilitation Radboud University Medical Center Nijmegen The Netherlands

5. Department of Laboratory Medicine, Translation Metabolic Laboratory Radboud University Medical Center Nijmegen The Netherlands

6. Institute for Molecules and Materials Radboud University Nijmegen The Netherlands

7. Department of Pharmacy Radboud University Medical Center Nijmegen The Netherlands

8. Radboud Institute for Health Sciences Radboud University Medical Center Nijmegen The Netherlands

9. Center of Expertise for Parkinson & Movement Disorders Radboud University Medical Center Nijmegen The Netherlands

10. Department for Health Evidence Radboud University Medical Center Nijmegen The Netherlands

11. Department of Pediatric Neurology Amalia Children's Hospital, Radboud University Medical Center Nijmegen The Netherlands

Funder

A-T Children's Project

Radboud Universitair Medisch Centrum

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28788

Reference22 articles.

1. Ataxia–telangiectasia, an evolving phenotype

2. ATAXIA-TELANGIECTASIA

3. Genotype, extrapyramidal features and severity of variant Ataxia‐Telangiectasia

4. Ataxia-telangiectasia: recommendations for multidisciplinary treatment

5. Therapeutic targets and investigated treatments for Ataxia-Telangiectasia

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of and challenges in targeting NAD+ metabolism;Nature Reviews Molecular Cell Biology;2024-07-18

2. The importance of synthetic pharmacotherapy for recessive cerebellar ataxias;Expert Review of Neurotherapeutics;2024-07-09

3. Nicotinamide riboside attenuates myocardial ischemia-reperfusion injury via regulating SIRT3/SOD2 signaling pathway;Biomedicine & Pharmacotherapy;2024-06

4. Ataxia telangiectasia or life in imbalance;Neurologie pro praxi;2024-04-16

5. Emerging therapies for childhood-onset movement disorders;Current Opinion in Pediatrics;2024-04-04